Cargando…
BTG2 suppresses renal cell carcinoma progression through N6-methyladenosine
The biological functions of N6-methyladenosine (m(6)A) modification of mRNA have recently received a great deal of attention. In previous studies, m(6)A methylation modification has been shown to regulate mRNA fate and to be crucial for the progression and development of tumors. BTG2 (B-cell translo...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9795213/ https://www.ncbi.nlm.nih.gov/pubmed/36591524 http://dx.doi.org/10.3389/fonc.2022.1049928 |